A detailed history of Usa Financial Portformulas Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Usa Financial Portformulas Corp holds 17,650 shares of BSX stock, worth $1.48 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
17,650
Previous 3,940 347.97%
Holding current value
$1.48 Million
Previous $269,000 405.2%
% of portfolio
0.22%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$67.33 - $77.71 $923,094 - $1.07 Million
13,710 Added 347.97%
17,650 $1.36 Million
Q1 2024

Apr 30, 2024

BUY
$57.6 - $68.62 $222,739 - $265,353
3,867 Added 5297.26%
3,940 $269,000
Q4 2023

Feb 07, 2024

SELL
$48.64 - $57.81 $1.06 Million - $1.26 Million
-21,849 Reduced 99.67%
73 $4,000
Q3 2023

Nov 27, 2023

BUY
$50.19 - $54.68 $87,882 - $95,744
1,751 Added 8.68%
21,922 $1.16 Million
Q2 2023

Nov 27, 2023

SELL
$49.72 - $54.64 $21,131 - $23,222
-425 Reduced 2.06%
20,171 $1.09 Million
Q1 2023

Nov 27, 2023

BUY
$45.09 - $50.03 $922,857 - $1.02 Million
20,467 Added 15865.89%
20,596 $1.03 Million
Q3 2022

Oct 24, 2022

BUY
$36.71 - $109.66 $2,496 - $7,456
68 Added 111.48%
129 $5,000
Q1 2022

Aug 16, 2022

BUY
$40.9 - $45.1 $1,513 - $1,668
37 Added 154.17%
61 $3,000
Q4 2021

Feb 10, 2022

SELL
$38.07 - $44.87 $837 - $987
-22 Reduced 47.83%
24 $1,000
Q3 2021

Nov 08, 2021

BUY
$41.23 - $45.88 $907 - $1,009
22 Added 91.67%
46 $2,000
Q4 2020

Jan 29, 2021

BUY
$33.15 - $41.97 $165 - $209
5 Added 26.32%
24 $1,000
Q2 2020

Aug 11, 2020

BUY
$30.19 - $39.11 $573 - $743
19 New
19 $1,000
Q1 2019

May 14, 2019

SELL
$32.91 - $40.75 $3.02 Million - $3.74 Million
-91,676 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$31.73 - $39.04 $2.91 Million - $3.58 Million
91,676 New
91,676 $3.53 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Usa Financial Portformulas Corp Portfolio

Follow Usa Financial Portformulas Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

News

Stay updated on Usa Financial Portformulas Corp with notifications on news.